Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V3-OVA Immunotherapy in Ovarian Cancer
NCT03556566Phase 2Unknown
- Sponsor
- Immunitor Inc.
- Start
- Jul 2018
- Primary completion
- Nov 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Oral cancer vaccine V3-OVA in ovarian cancer, sponsored by Immunitor Inc.. Status: unknown.
02
Drugs
Oral cancer vaccine V3-OVA
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03556566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03556566.